Title: DNA bending is a determinant of calicheamicin target recognition.
Authors: Salzberg, A A; Dedon, P C
Published In Biochemistry, (2000 Jun 27)
Abstract: Calicheamicin is a hydrophobic enediyne antibiotic that binds noncovalently to DNA and causes sequence-selective oxidation of deoxyribose. While the drug makes several base contacts along the minor groove, the diversity of binding-site sequences and the effects of DNA conformation on calicheamicin-induced DNA cleavage suggest that sequence recognition per se is not the primary determinant of target selection. We now present evidence that calicheamicin bends its DNA targets. Using a gel mobility assay, we observed that polymers of oligonucleotide constructs containing AGGA and ACAA binding sites for calicheamicin did not possess intrinsic curvature. Binding of calicheamicin epsilon, the aromatized form of the parent calicheamicin gamma(1)(I), to oligonucleotide constructs containing binding sites in phase with the helical repeat caused a shift to smaller circle sizes in T4 ligase-mediated circle formation assays, with a much smaller shift observed with constructs containing out-of-phase binding sites. It was also observed that binding of calicheamicin epsilon to a 273 bp construct with phased binding sites caused an increase in the molar cyclization factor, J, from 8 x 10(-8) to 9 x 10(-6) M. These results are consistent with DNA bending as part of an induced-fit mechanism of DNA target recognition and with the hypothesis that the preferred targets of calicheamicin, the 3' ends of oligopurine tracts, are characterized by unique conformational properties.
PubMed ID: 10858311
MeSH Terms: Aminoglycosides; Anti-Bacterial Agents/chemistry; Anti-Bacterial Agents/metabolism*; Base Sequence; Binding Sites; Catalysis; DNA Ligases/metabolism; DNA/chemistry*; Electrophoresis, Polyacrylamide Gel; Molecular Structure; Nucleic Acid Conformation*